JP2023545494A5 - - Google Patents
Info
- Publication number
- JP2023545494A5 JP2023545494A5 JP2023522950A JP2023522950A JP2023545494A5 JP 2023545494 A5 JP2023545494 A5 JP 2023545494A5 JP 2023522950 A JP2023522950 A JP 2023522950A JP 2023522950 A JP2023522950 A JP 2023522950A JP 2023545494 A5 JP2023545494 A5 JP 2023545494A5
- Authority
- JP
- Japan
- Prior art keywords
- capsule
- release
- controlled
- composition
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063092679P | 2020-10-16 | 2020-10-16 | |
| US63/092,679 | 2020-10-16 | ||
| PCT/US2021/054991 WO2022081848A1 (en) | 2020-10-16 | 2021-10-14 | Controlled release fill compositions and capsules containing same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023545494A JP2023545494A (ja) | 2023-10-30 |
| JP2023545494A5 true JP2023545494A5 (enExample) | 2024-10-16 |
Family
ID=81209315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023522950A Pending JP2023545494A (ja) | 2020-10-16 | 2021-10-14 | 制御放出充填組成物およびそれを含むカプセル |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230372252A1 (enExample) |
| EP (1) | EP4228608A4 (enExample) |
| JP (1) | JP2023545494A (enExample) |
| KR (1) | KR20230088730A (enExample) |
| CN (1) | CN116367864A (enExample) |
| AR (1) | AR123800A1 (enExample) |
| AU (2) | AU2021360905B2 (enExample) |
| CA (1) | CA3195386A1 (enExample) |
| CO (1) | CO2023005368A2 (enExample) |
| IL (1) | IL301692A (enExample) |
| MX (1) | MX2023004441A (enExample) |
| NZ (1) | NZ799086A (enExample) |
| TW (1) | TW202228655A (enExample) |
| WO (1) | WO2022081848A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240099982A1 (en) * | 2022-09-27 | 2024-03-28 | Gaia Herbs | Cellulose derivative free capsule for herbal extracts |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2627292C (en) * | 2005-10-26 | 2012-04-17 | Banner Pharmacaps, Inc. | Hydrophilic vehicle-based dual controlled release matrix system |
| US10960077B2 (en) * | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
| PE20141171A1 (es) * | 2011-10-06 | 2014-09-21 | Gruenenthal Chemie | Forma de dosificacion farmaceutica oral resistente a alteracion comprendiendo agonista opioide y antagonista opioide |
| US20150366814A1 (en) * | 2014-06-23 | 2015-12-24 | Banner Life Sciences Llc | All-natural enteric soft capsules comprising active ingredients |
| WO2016140933A2 (en) * | 2015-03-02 | 2016-09-09 | Bionpharma Healthcare Llc | Immediate release soluble ibuprofen compositions |
| EP3285746A1 (en) * | 2015-04-24 | 2018-02-28 | Grünenthal GmbH | Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a powder |
| WO2016170097A1 (en) * | 2015-04-24 | 2016-10-27 | Grünenthal GmbH | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
| US9943513B1 (en) * | 2015-10-07 | 2018-04-17 | Banner Life Sciences Llc | Opioid abuse deterrent dosage forms |
| EP3856160A4 (en) * | 2018-09-25 | 2022-07-06 | SpecGx LLC | ABUSE-PROOF IMMEDIATE RELEASE CAPSULE DOSAGE FORMS |
-
2021
- 2021-10-14 NZ NZ799086A patent/NZ799086A/en unknown
- 2021-10-14 KR KR1020237013939A patent/KR20230088730A/ko active Pending
- 2021-10-14 AU AU2021360905A patent/AU2021360905B2/en active Active
- 2021-10-14 CN CN202180070429.6A patent/CN116367864A/zh active Pending
- 2021-10-14 CA CA3195386A patent/CA3195386A1/en active Pending
- 2021-10-14 JP JP2023522950A patent/JP2023545494A/ja active Pending
- 2021-10-14 EP EP21881089.3A patent/EP4228608A4/en active Pending
- 2021-10-14 IL IL301692A patent/IL301692A/en unknown
- 2021-10-14 US US18/248,415 patent/US20230372252A1/en active Pending
- 2021-10-14 MX MX2023004441A patent/MX2023004441A/es unknown
- 2021-10-14 WO PCT/US2021/054991 patent/WO2022081848A1/en not_active Ceased
- 2021-10-15 AR ARP210102851A patent/AR123800A1/es unknown
- 2021-10-15 TW TW110138319A patent/TW202228655A/zh unknown
-
2023
- 2023-04-27 CO CONC2023/0005368A patent/CO2023005368A2/es unknown
-
2026
- 2026-03-05 AU AU2026201700A patent/AU2026201700A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6134788B2 (ja) | 疎水性組成物のための生分解性薬物送達 | |
| JP6072121B2 (ja) | リスペリドン徐放性ミクロスフェア組成物 | |
| AU2003240536B2 (en) | Reduction of gelatin cross-linking | |
| JPH10512845A (ja) | テブフェロンの固体分散組成物 | |
| TWI838700B (zh) | 口服紫杉烷組合物及方法 | |
| RU2009111588A (ru) | Системы доставки лекарственных средств, включающие в себя твердые растворы слабоосновных лекарственных средств | |
| CN106038492B (zh) | 一种制备缓释醋酸亮丙瑞林微球的制备方法 | |
| JPH10182426A (ja) | 医薬組成物及び医薬投与形状物 | |
| US10456378B2 (en) | Fast acting orally disintegrating film | |
| JP2023545494A5 (enExample) | ||
| DK2575784T3 (en) | ORAL DOSAGE FORMS OF BENDAMUSTIN | |
| RU2557919C1 (ru) | Сыпучий прессуемый порошок рапамицина и фармацевтическая композиция на его основе | |
| CN114903904B (zh) | 瑞马唑仑药用盐和阿片样物质的注射用药物组合物 | |
| CN106333930A (zh) | 一种阿齐沙坦微丸片及其制备方法 | |
| TW200824711A (en) | Embedded micellar nanoparticles | |
| SE405804B (sv) | Forfarande for framstellning av en kardiotonisk doseringsenhetsform | |
| CN108186597A (zh) | 一种鲁比前列酮固体分散体及其制备方法 | |
| CN108379227B (zh) | 一种包载芦丁的聚合物胶束及其制备方法 | |
| CN105287402B (zh) | 多西他赛聚合物胶束冻干制剂与专用溶剂的组合物 | |
| JP6605706B2 (ja) | 保存安定性が向上した医薬組成物及びその製造方法 | |
| JP2023547062A (ja) | 改変放出ソフトゲルカプセル | |
| TWI850346B (zh) | 於軟凝膠中改善api穩定性 | |
| US11464736B2 (en) | Thermally gelling drug formulations | |
| Castro et al. | Comparative plasma exposure of albendazole after administration of rapidly disintegrating tablets in dogs | |
| RU2812735C2 (ru) | Улучшенная стабильность активного фармацевтического соединения в мягких желатиновых капсулах |